Ventracor公司推出轻便心脏辅助系统

 
第三代心脏辅助系统可以作为心脏衰竭患者心脏移植的永久替代治疗方式。

VentrAssist系统是由Ventracor公司(Chatswood, NSW, Australia)生产的，是第三代左心室辅助设备(LVAD)，用于治疗心脏衰竭患者以提高生活质量。同时该系统还可以作为心脏移植的桥梁，还可能是通向康复的桥梁，从而给病变心脏一个恢复的机会。CE标记临床试验已经完成，投放欧洲市场的各项准备正在进行之中。

 
By medinews.com staff writers
 
A third-generation cardiac-assist system has been designed as a permanent alternative to a heart transplant for patients suffering from heart failure.

The VentrAssist system, manufactured by Ventracor (Chatswood, NSW, Australia), is a third-generation left-ventricle-assist device (LVAD) system designed to provide patients suffering from heart failure with better quality of life. It can also be used as a bridge to heart transplant and possibly as a bridge to recovery, where it may allow a deteriorating heart an opportunity to recuperate. The CE Mark trial has been completed, and preparations are underway for a European market launch.